Histone deacetylase inhibitor panobinostat in combination with rapamycin confers enhanced efficacy against triple-negative breast cancer
Author:
Publisher
Elsevier BV
Subject
Cell Biology
Reference42 articles.
1. Triple-negative breast cancer;Chacon;Breast Cancer Res.,2010
2. Management of triple negative breast cancer;Oakman;Breast,2010
3. Efficacy and safety of anti-trop-2 antibody drug conjugate Sacituzumab Govitecan (IMMU-132) in heavily pretreated patients with metastatic triple-negative breast cancer;Bardia;J. Clin. Oncol.,2017
4. Histone deacetylases as New therapeutic targets in triple-negative breast cancer: progress and promises;Garmpis;Cancer Genomics Proteomics,2017
5. Strategies to design selective histone deacetylase inhibitors;Melesina;ChemMedChem,2021
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anti-tumour activity of Panobinostat in oesophageal adenocarcinoma and squamous cell carcinoma cell lines;Clinical Epigenetics;2024-08-03
2. Emerging therapeutic strategies in cancer therapy by HDAC inhibition as the chemotherapeutic potent and epigenetic regulator;Medical Oncology;2024-03-05
3. Nurturing longevity through natural compounds: Where do we stand, and where do we go?;Food Frontiers;2024-01-10
4. Molecular mechanisms underlying the clinical efficacy of panobinostat involve Stochasticity of epigenetic signaling, sensitization to anticancer drugs, and induction of cellular cell death related to cellular stresses;Biomedicine & Pharmacotherapy;2023-08
5. Inhibition of histone deacetylases attenuates tumor progression and improves immunotherapy in breast cancer;Frontiers in Immunology;2023-03-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3